Literature DB >> 24322772

Reversing P-glycoprotein-mediated multidrug resistance in vitro by α-asarone and β-asarone, bioactive cis-trans isomers from Acorus tatarinowii.

Xue Meng1, Sha Liao, Xueyan Wang, Shixiang Wang, Xinfeng Zhao, Pu Jia, Weijing Pei, Xiaopu Zheng, Xiaohui Zheng.   

Abstract

P-Glycoprotein (P-gp), an ATP-binding cassette transporter, plays an important role in multidrug resistance (MDR). α-Asarone and β-asarone, bioactive cis-trans isomers found in Acorus tatarinowii Schott, were tested for their potential ability to modulate the expression and function of P-gp in Caco-2 cells. MTT assays revealed that both α-asarone and β-asarone significantly enhanced the vincristine-induced cytotoxicity to cells. β-Asarone was the most potent. Flow cytometry showed that α- and β-asarone increased Rhodamine 123 (Rh123) uptake and inhibited Rh123 efflux in Caco-2 cells in a concentration-dependent manner. Furthermore, P-gp expression and P-gp mRNA in cells were decreased by exposure to α- and β-asarone. In addition, β-asarone increased the inhibition of P-gp activity in cells more than α-asarone. Thus, α- and β-asarone effectively reversed MDR by inhibiting P-gp function and expression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24322772     DOI: 10.1007/s10529-013-1419-8

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  9 in total

1.  3-bromopyruvate enhanced daunorubicin-induced cytotoxicity involved in monocarboxylate transporter 1 in breast cancer cells.

Authors:  Zhe Liu; Yiming Sun; Haiyu Hong; Surong Zhao; Xue Zou; Renqiang Ma; Chenchen Jiang; Zhiwei Wang; Huabin Li; Hao Liu
Journal:  Am J Cancer Res       Date:  2015-08-15       Impact factor: 6.166

2.  Volatile Oil of Acori Graminei Rhizoma-Induced Apoptosis and Autophagy are dependent on p53 Status in Human Glioma Cells.

Authors:  Lu Chen; Zhuyun Jiang; Hui Ma; Ling Ning; Hongdan Chen; Li Li; Hongyi Qi
Journal:  Sci Rep       Date:  2016-02-19       Impact factor: 4.379

3.  Chrysosplenetin inhibits artemisinin efflux in P-gp-over-expressing Caco-2 cells and reverses P-gp/MDR1 mRNA up-regulated expression induced by artemisinin in mouse small intestine.

Authors:  Liping Ma; Shijie Wei; Bei Yang; Wei Ma; Xiuli Wu; Hongyan Ji; Hong Sui; Jing Chen
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

Review 4.  Experimental evidence for use of Acorus calamus (asarone) for cancer chemoprevention.

Authors:  Bhrigu Kumar Das; Ahm Viswanatha Swamy; Basavaraj C Koti; Pramod C Gadad
Journal:  Heliyon       Date:  2019-05-08

Review 5.  Potential Herb-Drug Interactions in the Management of Age-Related Cognitive Dysfunction.

Authors:  Maria D Auxtero; Susana Chalante; Mário R Abade; Rui Jorge; Ana I Fernandes
Journal:  Pharmaceutics       Date:  2021-01-19       Impact factor: 6.321

6.  Hepatotoxic potential of asarones: in vitro evaluation of hepatotoxicity and quantitative determination in herbal products.

Authors:  Dhavalkumar N Patel; Han K Ho; Liesbet L Tan; Mui-Mui B Tan; Qian Zhang; Min-Yong Low; Cheng-Leng Chan; Hwee-Ling Koh
Journal:  Front Pharmacol       Date:  2015-02-20       Impact factor: 5.810

Review 7.  Review of Scientific Evidence of Medicinal Convoy Plants in Traditional Persian Medicine.

Authors:  Seyede Nargess Sadati; Mohammad Reza Shams Ardekani; Nastaran Ebadi; Maryam Yakhchali; Azadeh Raees Dana; Fatemeh Masoomi; Mahnaz Khanavi; Farid Ramezany
Journal:  Pharmacogn Rev       Date:  2016 Jan-Jun

8.  β-Asarone Induces Apoptosis and Cell Cycle Arrest of Human Glioma U251 Cells via Suppression of HnRNP A2/B1-Mediated Pathway In Vitro and In Vivo.

Authors:  Li Li; Yi Yang; Mingxia Wu; Zanyang Yu; Chengqiang Wang; Guojun Dou; Hui He; Hongmei Wang; Na Yang; Hongyi Qi; Xiaoyu Xu
Journal:  Molecules       Date:  2018-05-03       Impact factor: 4.411

9.  β-Asarone Inhibits Invasion and EMT in Human Glioma U251 Cells by Suppressing Splicing Factor HnRNP A2/B1.

Authors:  Li Li; Mingxia Wu; Chengqiang Wang; Zanyang Yu; Hongmei Wang; Hongyi Qi; Xiaoyu Xu
Journal:  Molecules       Date:  2018-03-16       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.